Sandoz Launches First Biosimilar At 15% Discount
Sandoz Inc. on Thursday began U.S. sales of anti-infection biosimilar Zarxio, offering a 15 percent discount on Amgen Inc.'s Neupogen in a milestone for efforts to rein in sky-high spending on...To view the full article, register now.
Already a subscriber? Click here to view full article